Response to “Quantitative Prediction of Drug‐Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is It Worth?”

• IE Templeton,
• Y Chen,
• J Mao,
• J Lin,
• H Yu,
• S Peters,
• M Shebley,
• MV Varma

Affiliations

IE Templeton

Genentech, South San Francisco California USA

Y Chen

Genentech, South San Francisco California USA

J Mao

Genentech, South San Francisco California USA

J Lin

Pfizer Inc., Groton Connecticut USA

H Yu

Boehringer Ingelheim PharmaceuticalsRidgefield Connecticut USA

S Peters

Merck SeronoDarmstadt Hessen Germany

M Shebley

AbbVie Inc.North Chicago Illinois USA

MV Varma

Pfizer Inc., Groton Connecticut USA